According to Zacks, “RTI Surgical Inc. is a surgical implant company. Its implants are used in sports medicine, general surgery, spine, orthopedic, trauma and cardiothoracic procedures. RTI Surgical Inc., formerly known as RTI Biologics, Inc., is headquartered in Alachua, Fla. “
Separately, Craig Hallum lowered shares of RTI Surgical from a buy rating to a hold rating and decreased their price target for the company from $6.00 to $4.00 in a research note on Thursday, July 28th.
RTI Surgical (NASDAQ:RTIX) traded up 0.32% during mid-day trading on Wednesday, hitting $3.11. 8,376 shares of the stock were exchanged. RTI Surgical has a 52 week low of $2.81 and a 52 week high of $5.74. The stock’s 50-day moving average is $3.20 and its 200 day moving average is $3.65. The company has a market capitalization of $179.67 million, a PE ratio of 43.80 and a beta of 1.44.
RTI Surgical (NASDAQ:RTIX) last announced its quarterly earnings results on Wednesday, July 27th. The company reported ($0.05) EPS for the quarter, missing the Zacks’ consensus estimate of $0.03 by $0.08. The business had revenue of $67.60 million for the quarter, compared to the consensus estimate of $66.52 million. RTI Surgical had a net margin of 2.80% and a return on equity of 6.51%. The business’s revenue for the quarter was down 5.6% compared to the same quarter last year. During the same quarter last year, the firm posted $0.04 EPS. On average, analysts anticipate that RTI Surgical will post $0.10 EPS for the current year.
Several hedge funds have recently bought and sold shares of RTIX. Metropolitan Life Insurance Co. NY raised its stake in RTI Surgical by 1.9% in the first quarter. Metropolitan Life Insurance Co. NY now owns 42,735 shares of the company’s stock valued at $171,000 after buying an additional 783 shares during the last quarter. Analytic Investors LLC raised its stake in RTI Surgical by 0.7% in the second quarter. Analytic Investors LLC now owns 215,927 shares of the company’s stock valued at $775,000 after buying an additional 1,492 shares during the last quarter. Alliancebernstein L.P. raised its stake in RTI Surgical by 4.6% in the second quarter. Alliancebernstein L.P. now owns 59,049 shares of the company’s stock valued at $212,000 after buying an additional 2,600 shares during the last quarter. Ancora Advisors LLC raised its stake in RTI Surgical by 1.4% in the second quarter. Ancora Advisors LLC now owns 211,000 shares of the company’s stock valued at $757,000 after buying an additional 3,000 shares during the last quarter. Finally, Numeric Investors LLC raised its stake in RTI Surgical by 14.0% in the second quarter. Numeric Investors LLC now owns 68,196 shares of the company’s stock valued at $245,000 after buying an additional 8,400 shares during the last quarter. Hedge funds and other institutional investors own 78.97% of the company’s stock.
RTI Surgical Company Profile
RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for RTI Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.